Centre of Excellence Remote and Decentralised Clinical Trials

Trials@Home aims to reshape clinical trial design, conduct and operations, by developing and piloting standards, recommendations and tools for the definition and operationalisation of remote decentralised clinical trials (RDCTs) in Europe.

Centre of Excellence Remote and Decentralised Clinical Trials

Trials@Home aims to reshape clinical trial design, conduct and operations, by developing and piloting standards, recommendations and tools for the definition and operationalisation of remote decentralised clinical trials (RDCTs) in Europe.

*

Key objectives:

  • Defining the best practices for the conduct of RDCTs.

  • Identifying technologies and other operational innovative approaches for RDCTs and selecting the appropriate technology package to be used for the pan-EU pilot.

  • Designing and running a pan-EU pilot, comparing the scientific and operational quality of the RDCT with traditional trial approaches and evaluating the feasibility of the RDCT.

  • Identifying, mapping and analysing the relevant ethical, quality, regulatory, legal and organisational barriers and enablers of RDCTs.

  • Consulting with stakeholders and promoting the outcomes from the Trials@Home consortium through targeted communication, dissemination and training activities.

  • Providing recommendations with supporting tools for implementing RDCTs in Europe and contributing to the update of ICH guidelines on RDCTs.

More
*

About us

*

About RDCT’s

*

About the ESP

News & publications

*

Innovative Medicines Initiative Launches ‘Trials@Home’

A major European project to bring clinical trials to the participant’s home

Utrecht, October 7, 2019
Follow us on Twitter
Sign up for our Newsletter